Trevi Therapeutics
TRVI
#4825
Rank
S$2.72 B
Marketcap
S$19.15
Share price
-5.35%
Change (1 day)
85.31%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -S$60.76 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$55.94 Million, an increase over its 2024 earnings that were of -S$61.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$60.76 Million8.61%
2025 -S$55.94 Million-8.34%
2024 -S$61.03 Million67%
2023 -S$36.55 Million2.43%
2022 -S$35.68 Million-14.45%
2021 -S$41.71 Million1.36%
2020 -S$41.15 Million23.64%
2019 -S$33.28 Million27.54%
2018 -S$26.1 Million